LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924
Background: The mortality and morbidity rates of pancreatic adenocarcinoma have been increasing over the past two decades, and an understanding of the mechanisms underlying pancreatic adenocarcinoma progression is urgently needed. The long non-coding RNA ZFAS1 has been demonstrated to be an oncogene in some cancers, but its function and mechanism in pancreatic adenocarcinoma remain unclear.
Methods: The ZFAS1 expression level in pancreatic adenocarcinoma was predicted by bioinformatic analysis, and the expression level of ZFAS1 in pancreatic adenocarcinoma tissue samples and cell lines was further investigated by quantitative real-time PCR and in situ hybridization. The functions of ZFAS1 in pancreatic adenocarcinoma in vitro and in vivo were investigated by further bioinformatic analysis. Dual-luciferase reporter assays were used to investigate the binding of ZFAS1/miR-3924 and miR-3924/ROCK2, and rescue assays were performed to further investigate the underlying mechanism.
Results: ZFAS1 overexpression in pancreatic adenocarcinoma was predicted and experimentally verified. ZFAS1 silencing inhibited pancreatic adenocarcinoma metastasis in vitro and in vivo. The competing endogenous RNA mechanism of ZFAS1 was also identified.
Conclusions: Our results demonstrated the promotive effect of ZFAS1 on pancreatic adenocarcinoma metastasis and suggested its potential role as a novel regulator of ROCK2.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
This is a list of supplementary files associated with this preprint. Click to download.
Posted 10 Jun, 2020
On 16 Jun, 2020
On 02 Jun, 2020
On 01 Jun, 2020
Invitations sent on 01 Jun, 2020
On 01 Jun, 2020
On 01 Jun, 2020
Received 01 Jun, 2020
Received 01 Jun, 2020
On 31 May, 2020
On 31 May, 2020
On 02 May, 2020
Received 01 May, 2020
Received 23 Apr, 2020
On 18 Apr, 2020
On 18 Apr, 2020
On 15 Apr, 2020
Invitations sent on 15 Apr, 2020
On 14 Apr, 2020
On 08 Apr, 2020
On 07 Apr, 2020
LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924
Posted 10 Jun, 2020
On 16 Jun, 2020
On 02 Jun, 2020
On 01 Jun, 2020
Invitations sent on 01 Jun, 2020
On 01 Jun, 2020
On 01 Jun, 2020
Received 01 Jun, 2020
Received 01 Jun, 2020
On 31 May, 2020
On 31 May, 2020
On 02 May, 2020
Received 01 May, 2020
Received 23 Apr, 2020
On 18 Apr, 2020
On 18 Apr, 2020
On 15 Apr, 2020
Invitations sent on 15 Apr, 2020
On 14 Apr, 2020
On 08 Apr, 2020
On 07 Apr, 2020
Background: The mortality and morbidity rates of pancreatic adenocarcinoma have been increasing over the past two decades, and an understanding of the mechanisms underlying pancreatic adenocarcinoma progression is urgently needed. The long non-coding RNA ZFAS1 has been demonstrated to be an oncogene in some cancers, but its function and mechanism in pancreatic adenocarcinoma remain unclear.
Methods: The ZFAS1 expression level in pancreatic adenocarcinoma was predicted by bioinformatic analysis, and the expression level of ZFAS1 in pancreatic adenocarcinoma tissue samples and cell lines was further investigated by quantitative real-time PCR and in situ hybridization. The functions of ZFAS1 in pancreatic adenocarcinoma in vitro and in vivo were investigated by further bioinformatic analysis. Dual-luciferase reporter assays were used to investigate the binding of ZFAS1/miR-3924 and miR-3924/ROCK2, and rescue assays were performed to further investigate the underlying mechanism.
Results: ZFAS1 overexpression in pancreatic adenocarcinoma was predicted and experimentally verified. ZFAS1 silencing inhibited pancreatic adenocarcinoma metastasis in vitro and in vivo. The competing endogenous RNA mechanism of ZFAS1 was also identified.
Conclusions: Our results demonstrated the promotive effect of ZFAS1 on pancreatic adenocarcinoma metastasis and suggested its potential role as a novel regulator of ROCK2.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6